Neuroendocrinology
Original Paper
Streptozotocin-Induced Diabetes Is Associated with Reduced Immunoreactive Beta-Endorphin Concentrations in Neurointermediate Pituitary Lobe and with Disrupted Circadian Periodicity of Plasma Corticosterone LevelsGibson M.J.a · DeNicola A.F.b · Krieger D.T.aaDivision of Endocrinology, Department of Medicine, Mount Sinai School of Medicine, New York, N.Y., USA; bInstituto de Biologia y Medicina Experimental, Buenos Aires, Argentina
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: April 23, 1984
Accepted: October 04, 1984
Published online: March 28, 2008
Issue release date: 1985
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Abstract
Lower concentrations of immunoreactive (IR) β-endorphin were present in the neurointermediate pituitary lobes of streptozotocin-induced diabetic versus control animals at both 2 and 4 weeks after the onset of diabetes. The forms of β-endorphin-like material present appeared to be similar in both groups when studied with cation-exchange chromatography. Insulin therapy via minipump for 2 weeks did not alter this finding of lowered β-endorphin concentrations in diabetic animals, despite normalization of blood glucose levels and body weight gain. Lower IR β-endorphin levels were also found in neurointermediate lobes of weight-restricted rats, but this group had increased plasma IR β-endorphin concentrations compared to diabetic animals. Concentrations of IR β-endorphin in microdissected brain regions and in anterior pituitaries of the diabetic animals failed to show consistent changes; in addition, ACTH concentrations in pituitary lobes and plasma did not differ among groups. Circadian rhythmicity of plasma insulin and corticosterone concentrations was absent in the diabetic animals, although food and water intake, while elevated, showed the normal nocturnal pattern of increased ingestion. Furthermore, adrenal hypertrophy was present in the diabetic animals and was accompanied by an elevation of mean plasma corticosterone levels. The present findings indicate that diabetes is associated with a decrease of neurointermediate pituitary lobe synthesis of β-endorphin, while not affecting the processing of the peptide in this lobe, and confirm previous reports of altered adrenal function in diabetic animals.
© 1985 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: April 23, 1984
Accepted: October 04, 1984
Published online: March 28, 2008
Issue release date: 1985
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
